Colomer Ramón, Menéndez Javier A
Medical Oncology, Institut Catala d'Oncologia, Hospital de Girona Dr. Josep Trueta, Girona, Spain.
Clin Transl Oncol. 2006 Jan;8(1):15-21. doi: 10.1007/s12094-006-0090-0.
Olive oil is an integral ingredient of the "Mediterranean diet" and accumulating evidence suggests that it may have a potential role in lowering the risk of several types of cancers. The mechanisms by which the cancer-preventing effects of olive oil can be performed, however, are not known. We recently hypothesized that a novel molecular explanation concerning the anti-cancer actions of olive oil may relate to the ability of its monounsaturated fatty acid (MUFA) oleic acid (OA; 18:1n-9) to specifically regulate cancer-related oncogenes. Supporting our hypothesis, exogenous supplementation of cultured breast cancer cells with physiological concentrations of OA was found to suppress the overexpression of HER2 (Her-2/neu, erbB-2), a well-characterized oncogene playing a key role in the etiology, progression and response to chemotherapy and endocrine therapy in approximately 20% of breast carcinomas. OA treatment was also found to synergistically enhance the efficacy of trastuzumab, a humanized monoclonal antibody binding with high affinity to the ectodomain (ECD) of the Her2-coded p185(HER2) oncoprotein. Moreover, OA exposure significantly diminished the proteolytic cleavage of the ECD of HER2 and, consequently, its activation status, a crucial molecular event that determines both the aggressive behavior and the response to trastuzumab of Her2-overexpressing breast carcinomas. Our most recent findings further reveal that OA exposure may suppresses HER2 at the transcriptional level by up-regulating the expression of the Ets protein PEA3 -a DNA-binding protein that specifically blocks HER2 promoter activity- in breast, ovarian and stomach cancer cell lines. This anti-HER2 property of OA offers a previously unrecognized molecular mechanism by which olive oil may regulate the malignant behavior of cancer cells. From a clinical perspective, it could provide an effective means of influencing the outcome of Her-2/neu-overexpressing human carcinomas with poor prognosis. Indeed, OA-induced transcriptional repression of HER2 oncogene may represent a novel genomic explanation linking "Mediterranean diet", olive oil and cancer as it seems to equally operate in various types of Her-2/neu-related carcinomas.
橄榄油是“地中海饮食”的重要组成部分,越来越多的证据表明它可能在降低多种癌症风险方面发挥潜在作用。然而,橄榄油防癌作用的机制尚不清楚。我们最近推测,一种关于橄榄油抗癌作用的新分子解释可能与其单不饱和脂肪酸(MUFA)油酸(OA;18:1n-9)特异性调节癌症相关癌基因的能力有关。支持我们这一假设的是,发现用生理浓度的OA对培养的乳腺癌细胞进行外源补充可抑制HER2(Her-2/neu,erbB-2)的过表达,HER2是一种特征明确的癌基因,在约20%的乳腺癌的病因、进展以及对化疗和内分泌治疗的反应中起关键作用。还发现OA治疗可协同增强曲妥珠单抗的疗效,曲妥珠单抗是一种与人源化单克隆抗体,可与Her2编码的p185(HER2)癌蛋白的胞外域(ECD)高亲和力结合。此外,OA处理显著减少了HER2胞外域的蛋白水解切割,从而降低了其激活状态,这是一个关键的分子事件,它决定了HER2过表达乳腺癌的侵袭性行为和对曲妥珠单抗的反应。我们最近的研究结果进一步表明,在乳腺癌、卵巢癌和胃癌细胞系中,OA处理可能通过上调Ets蛋白PEA3的表达在转录水平上抑制HER2,PEA3是一种DNA结合蛋白,可特异性阻断HER2启动子活性。OA的这种抗HER2特性提供了一种以前未被认识的分子机制,通过该机制橄榄油可能调节癌细胞的恶性行为。从临床角度来看,它可能提供一种有效的手段来影响预后不良的Her-2/neu过表达人类癌症的结局。事实上,OA诱导的HER2癌基因转录抑制可能代表了一种将“地中海饮食”、橄榄油和癌症联系起来的新基因组解释,因为它似乎在各种类型的Her-2/neu相关癌症中同样起作用。